| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | 1.56e-05 | 279 | 39 | 6 | GO:0005096 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 4.82e-05 | 206 | 39 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | histone binding | 1.58e-04 | 265 | 39 | 5 | GO:0042393 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 2.46e-04 | 656 | 39 | 7 | GO:0008047 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 4.16e-04 | 507 | 39 | 6 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 4.16e-04 | 507 | 39 | 6 | GO:0060589 | |
| GeneOntologyMolecularFunction | methylated histone binding | 6.30e-04 | 86 | 39 | 3 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 6.74e-04 | 88 | 39 | 3 | GO:0140034 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 9.87e-04 | 1356 | 39 | 9 | GO:0060090 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 1.17e-03 | 26 | 39 | 2 | GO:0004435 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 1.46e-03 | 29 | 39 | 2 | GO:0004629 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.59e-03 | 441 | 39 | 5 | GO:0016887 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.81e-03 | 303 | 39 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | small GTPase binding | 3.46e-03 | 321 | 39 | 4 | GO:0031267 | |
| GeneOntologyMolecularFunction | helicase activity | 3.61e-03 | 158 | 39 | 3 | GO:0004386 | |
| GeneOntologyBiologicalProcess | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration | 3.67e-06 | 2 | 40 | 2 | GO:0021816 | |
| GeneOntologyBiologicalProcess | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration | 3.65e-05 | 5 | 40 | 2 | GO:0021815 | |
| GeneOntologyBiologicalProcess | chromatin organization | 4.29e-05 | 896 | 40 | 9 | GO:0006325 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 7.41e-05 | 741 | 40 | 8 | GO:0006338 | |
| GeneOntologyBiologicalProcess | cell motility involved in cerebral cortex radial glia guided migration | 7.65e-05 | 7 | 40 | 2 | GO:0021814 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 9.94e-05 | 999 | 40 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | negative regulation of cell migration | 1.45e-04 | 419 | 40 | 6 | GO:0030336 | |
| GeneOntologyBiologicalProcess | negative regulation of cell motility | 1.78e-04 | 435 | 40 | 6 | GO:2000146 | |
| GeneOntologyBiologicalProcess | negative regulation of locomotion | 2.24e-04 | 454 | 40 | 6 | GO:0040013 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | 2.71e-04 | 670 | 40 | 7 | GO:0120031 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 2.72e-04 | 65 | 40 | 3 | GO:0045815 | |
| GeneOntologyBiologicalProcess | cell projection assembly | 3.10e-04 | 685 | 40 | 7 | GO:0030031 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 3.10e-04 | 68 | 40 | 3 | GO:0141137 | |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in determination of left/right asymmetry | 3.79e-04 | 15 | 40 | 2 | GO:0060287 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | 4.19e-04 | 720 | 40 | 7 | GO:0000226 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 4.54e-04 | 186 | 40 | 4 | GO:0006367 | |
| GeneOntologyBiologicalProcess | inositol trisphosphate metabolic process | 4.90e-04 | 17 | 40 | 2 | GO:0032957 | |
| GeneOntologyBiologicalProcess | inner dynein arm assembly | 4.90e-04 | 17 | 40 | 2 | GO:0036159 | |
| GeneOntologyBiologicalProcess | pseudopodium assembly | 4.90e-04 | 17 | 40 | 2 | GO:0031269 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 5.52e-04 | 350 | 40 | 5 | GO:0051321 | |
| GeneOntologyBiologicalProcess | pseudopodium organization | 6.14e-04 | 19 | 40 | 2 | GO:0031268 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 6.19e-04 | 202 | 40 | 4 | GO:0051963 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 9.85e-04 | 24 | 40 | 2 | GO:0048015 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 1.02e-03 | 231 | 40 | 4 | GO:0006352 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 1.23e-03 | 109 | 40 | 3 | GO:0035082 | |
| GeneOntologyCellularComponent | kinetochore | 2.37e-05 | 181 | 40 | 5 | GO:0000776 | |
| GeneOntologyCellularComponent | condensed chromosome | 2.41e-05 | 307 | 40 | 6 | GO:0000793 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 3.22e-05 | 193 | 40 | 5 | GO:0000779 | |
| GeneOntologyCellularComponent | chromosomal region | 1.38e-04 | 421 | 40 | 6 | GO:0098687 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.74e-04 | 276 | 40 | 5 | GO:0000775 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 2.04e-04 | 1377 | 40 | 10 | GO:0140513 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.38e-03 | 254 | 40 | 4 | GO:0000228 | |
| GeneOntologyCellularComponent | microtubule organizing center | 1.62e-03 | 919 | 40 | 7 | GO:0005815 | |
| Domain | FCH | 6.81e-10 | 22 | 38 | 5 | PF00611 | |
| Domain | FCH | 6.81e-10 | 22 | 38 | 5 | SM00055 | |
| Domain | FCH_dom | 8.69e-10 | 23 | 38 | 5 | IPR001060 | |
| Domain | F_BAR | 1.37e-09 | 25 | 38 | 5 | IPR031160 | |
| Domain | F_BAR | 1.37e-09 | 25 | 38 | 5 | PS51741 | |
| Domain | srGAP2 | 7.77e-09 | 3 | 38 | 3 | IPR030252 | |
| Domain | RhoGAP | 2.71e-04 | 62 | 38 | 3 | SM00324 | |
| Domain | RhoGAP | 2.84e-04 | 63 | 38 | 3 | PF00620 | |
| Domain | RHOGAP | 2.97e-04 | 64 | 38 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 2.97e-04 | 64 | 38 | 3 | IPR000198 | |
| Domain | - | 2.97e-04 | 64 | 38 | 3 | 1.10.555.10 | |
| Domain | SH3_1 | 3.35e-04 | 164 | 38 | 4 | PF00018 | |
| Domain | PIPLC_Y_DOMAIN | 4.16e-04 | 15 | 38 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 4.16e-04 | 15 | 38 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 4.16e-04 | 15 | 38 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 4.16e-04 | 15 | 38 | 2 | PF00387 | |
| Domain | PLipase_C_Pinositol-sp_Y | 4.16e-04 | 15 | 38 | 2 | IPR001711 | |
| Domain | EF-hand_like | 4.16e-04 | 15 | 38 | 2 | PF09279 | |
| Domain | PLCYc | 4.16e-04 | 15 | 38 | 2 | SM00149 | |
| Domain | PI-PLC-X | 6.04e-04 | 18 | 38 | 2 | PF00388 | |
| Domain | Chromodomain_CS | 6.04e-04 | 18 | 38 | 2 | IPR023779 | |
| Domain | PLCXc | 6.04e-04 | 18 | 38 | 2 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 6.74e-04 | 19 | 38 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 6.74e-04 | 19 | 38 | 2 | IPR000909 | |
| Domain | Rho_GTPase_activation_prot | 7.57e-04 | 88 | 38 | 3 | IPR008936 | |
| Domain | SH3 | 9.44e-04 | 216 | 38 | 4 | PS50002 | |
| Domain | SH3 | 9.44e-04 | 216 | 38 | 4 | SM00326 | |
| Domain | SH3_domain | 1.01e-03 | 220 | 38 | 4 | IPR001452 | |
| Domain | Chromo_domain | 1.08e-03 | 24 | 38 | 2 | IPR023780 | |
| Domain | - | 1.17e-03 | 25 | 38 | 2 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 1.17e-03 | 25 | 38 | 2 | IPR017946 | |
| Domain | Chromo | 1.27e-03 | 26 | 38 | 2 | PF00385 | |
| Domain | CHROMO_2 | 1.47e-03 | 28 | 38 | 2 | PS50013 | |
| Domain | CHROMO_1 | 1.47e-03 | 28 | 38 | 2 | PS00598 | |
| Domain | Chromodomain-like | 1.92e-03 | 32 | 38 | 2 | IPR016197 | |
| Domain | CHROMO | 2.05e-03 | 33 | 38 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 2.05e-03 | 33 | 38 | 2 | IPR000953 | |
| Domain | DEAH_ATP_HELICASE | 2.71e-03 | 38 | 38 | 2 | PS00690 | |
| Domain | TBC | 4.46e-03 | 49 | 38 | 2 | SM00164 | |
| Domain | RabGAP-TBC | 5.20e-03 | 53 | 38 | 2 | PF00566 | |
| Domain | TBC_RABGAP | 5.59e-03 | 55 | 38 | 2 | PS50086 | |
| Domain | Rab-GTPase-TBC_dom | 5.59e-03 | 55 | 38 | 2 | IPR000195 | |
| Pathway | REACTOME_INACTIVATION_OF_CDC42_AND_RAC1 | 3.49e-07 | 8 | 27 | 3 | M27349 | |
| Pathway | PID_AURORA_B_PATHWAY | 5.47e-05 | 39 | 27 | 3 | M14 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.07e-04 | 254 | 27 | 5 | M27131 | |
| Pathway | WP_GPR40_PATHWAY | 3.65e-04 | 15 | 27 | 2 | M39526 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 22559944 | ||
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 19137586 | ||
| Pubmed | Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication. | 5.63e-09 | 4 | 40 | 3 | 22559943 | |
| Pubmed | SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance. | 2.81e-08 | 6 | 40 | 3 | 33514561 | |
| Pubmed | 2.81e-08 | 6 | 40 | 3 | 12736724 | ||
| Pubmed | 2.81e-08 | 6 | 40 | 3 | 11672528 | ||
| Pubmed | 4.92e-08 | 7 | 40 | 3 | 21655271 | ||
| Pubmed | 1.63e-07 | 1014 | 40 | 10 | 32416067 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 1.66e-07 | 109 | 40 | 5 | 33554859 | |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 3.88e-07 | 248 | 40 | 6 | 27926873 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.91e-07 | 608 | 40 | 8 | 36089195 | |
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 5.27e-07 | 56 | 40 | 4 | 26919559 | |
| Pubmed | 9.84e-07 | 469 | 40 | 7 | 27634302 | ||
| Pubmed | Phospholipase C isoforms are localized at the cleavage furrow during cytokinesis. | 1.29e-06 | 2 | 40 | 2 | 17041247 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 33984363 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23505444 | ||
| Pubmed | FF domains of CA150 bind transcription and splicing factors through multiple weak interactions. | 1.29e-06 | 2 | 40 | 2 | 15485897 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 37474847 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 31822692 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 27373832 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 22271578 | ||
| Pubmed | The transcriptional transactivator Tat selectively regulates viral splicing. | 3.87e-06 | 3 | 40 | 2 | 19966273 | |
| Pubmed | Heterochromatin links to centromeric protection by recruiting shugoshin. | 3.87e-06 | 3 | 40 | 2 | 18716626 | |
| Pubmed | 5.50e-06 | 1497 | 40 | 10 | 31527615 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 9188725 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 11056214 | ||
| Pubmed | Molecular cloning and characterization of a novel phospholipase C, PLC-eta. | 7.73e-06 | 4 | 40 | 2 | 15702972 | |
| Pubmed | 9.88e-06 | 250 | 40 | 5 | 33536335 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.10e-05 | 954 | 40 | 8 | 36373674 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 21346195 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.83e-05 | 1024 | 40 | 8 | 24711643 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 2.05e-05 | 495 | 40 | 6 | 27705803 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 2.60e-05 | 1415 | 40 | 9 | 28515276 | |
| Pubmed | Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. | 2.66e-05 | 50 | 40 | 3 | 19807924 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 2.75e-05 | 1425 | 40 | 9 | 30948266 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 3.11e-05 | 533 | 40 | 6 | 30554943 | |
| Pubmed | 4.26e-05 | 1153 | 40 | 8 | 29845934 | ||
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 7589147 | ||
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 10501179 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 4.88e-05 | 349 | 40 | 5 | 25665578 | |
| Pubmed | Expression of phospholipase C isozymes by murine B lymphocytes. | 5.77e-05 | 10 | 40 | 2 | 2033248 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 6.27e-05 | 605 | 40 | 6 | 28977666 | |
| Pubmed | 7.50e-05 | 916 | 40 | 7 | 32203420 | ||
| Pubmed | Huntingtin interacting proteins are genetic modifiers of neurodegeneration. | 7.78e-05 | 197 | 40 | 4 | 17500595 | |
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 19486527 | ||
| Pubmed | 8.92e-05 | 645 | 40 | 6 | 25281560 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 9.56e-05 | 1294 | 40 | 8 | 30804502 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.09e-04 | 1318 | 40 | 8 | 30463901 | |
| Pubmed | 1.16e-04 | 14 | 40 | 2 | 20231385 | ||
| Pubmed | Interactions of MCP1 with components of the replication machinery in mammalian cells. | 1.16e-04 | 14 | 40 | 2 | 21383955 | |
| Pubmed | 1.16e-04 | 14 | 40 | 2 | 21875947 | ||
| Pubmed | 1.16e-04 | 14 | 40 | 2 | 8605874 | ||
| Pubmed | 1.28e-04 | 689 | 40 | 6 | 36543142 | ||
| Pubmed | 1.30e-04 | 225 | 40 | 4 | 12168954 | ||
| Pubmed | Nucleosome-interacting proteins regulated by DNA and histone methylation. | 1.34e-04 | 15 | 40 | 2 | 21029866 | |
| Pubmed | 1.46e-04 | 441 | 40 | 5 | 31239290 | ||
| Pubmed | 1.76e-04 | 94 | 40 | 3 | 16325481 | ||
| Pubmed | 1.89e-04 | 1429 | 40 | 8 | 35140242 | ||
| Pubmed | A Non-catalytic Function of SETD1A Regulates Cyclin K and the DNA Damage Response. | 1.95e-04 | 18 | 40 | 2 | 29474905 | |
| Pubmed | 1.95e-04 | 18 | 40 | 2 | 1979339 | ||
| Pubmed | 1.97e-04 | 251 | 40 | 4 | 28077445 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.06e-04 | 475 | 40 | 5 | 31040226 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.10e-04 | 1082 | 40 | 7 | 38697112 | |
| Pubmed | Genome-wide association with bone mass and geometry in the Framingham Heart Study. | 2.18e-04 | 19 | 40 | 2 | 17903296 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 2.29e-04 | 486 | 40 | 5 | 30940648 | |
| Pubmed | 2.67e-04 | 21 | 40 | 2 | 26468281 | ||
| Pubmed | 2.67e-04 | 21 | 40 | 2 | 17562788 | ||
| Pubmed | 3.21e-04 | 23 | 40 | 2 | 9730685 | ||
| Pubmed | 3.21e-04 | 23 | 40 | 2 | 9278385 | ||
| Pubmed | 3.50e-04 | 24 | 40 | 2 | 17540172 | ||
| Pubmed | 3.50e-04 | 24 | 40 | 2 | 10843712 | ||
| Pubmed | 3.66e-04 | 538 | 40 | 5 | 28524877 | ||
| Pubmed | 3.97e-04 | 124 | 40 | 3 | 20850016 | ||
| Pubmed | ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. | 4.12e-04 | 26 | 40 | 2 | 34162889 | |
| Pubmed | 4.45e-04 | 27 | 40 | 2 | 20336759 | ||
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 4.76e-04 | 132 | 40 | 3 | 16944949 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 5.01e-04 | 321 | 40 | 4 | 32098917 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 5.19e-04 | 1257 | 40 | 7 | 36526897 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 5.48e-04 | 588 | 40 | 5 | 38580884 | |
| Pubmed | Isolation and characterization of proteins associated with histone H3 tails in vivo. | 5.50e-04 | 30 | 40 | 2 | 17403666 | |
| Pubmed | 5.50e-04 | 30 | 40 | 2 | 37321213 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 5.67e-04 | 910 | 40 | 6 | 36736316 | |
| Pubmed | 5.75e-04 | 333 | 40 | 4 | 36779763 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 6.39e-04 | 146 | 40 | 3 | 23892456 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 6.50e-04 | 934 | 40 | 6 | 33916271 | |
| Pubmed | The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor. | 6.66e-04 | 33 | 40 | 2 | 9765201 | |
| Pubmed | Genetic mapping of the human and mouse phospholipase C genes. | 6.66e-04 | 33 | 40 | 2 | 8672127 | |
| Pubmed | 6.66e-04 | 33 | 40 | 2 | 30783098 | ||
| Pubmed | 6.71e-04 | 615 | 40 | 5 | 31048545 | ||
| Pubmed | 7.05e-04 | 151 | 40 | 3 | 17043677 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 7.06e-04 | 949 | 40 | 6 | 36574265 | |
| Pubmed | Choroid plexuses carry nodal-like cilia that undergo axoneme regression from early adult stage. | 7.49e-04 | 35 | 40 | 2 | 37890489 | |
| Pubmed | 7.89e-04 | 157 | 40 | 3 | 30186101 | ||
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 8.83e-04 | 38 | 40 | 2 | 12482669 | |
| Pubmed | 9.21e-04 | 660 | 40 | 5 | 32780723 | ||
| Pubmed | 9.76e-04 | 169 | 40 | 3 | 31462741 | ||
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 1.03e-03 | 41 | 40 | 2 | 20431927 | |
| Pubmed | Functional dissection of Rab GTPases involved in primary cilium formation. | 1.13e-03 | 43 | 40 | 2 | 17646400 | |
| Pubmed | 1.13e-03 | 43 | 40 | 2 | 19077034 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 1.13e-03 | 178 | 40 | 3 | 27637333 | |
| Interaction | H3-4 interactions | 2.31e-06 | 448 | 40 | 8 | int:H3-4 | |
| Interaction | H3-3B interactions | 2.98e-06 | 114 | 40 | 5 | int:H3-3B | |
| Interaction | H3-3A interactions | 1.25e-05 | 749 | 40 | 9 | int:H3-3A | |
| Interaction | H2BC8 interactions | 1.46e-05 | 576 | 40 | 8 | int:H2BC8 | |
| Interaction | CIT interactions | PHF2 MCM7 YTHDC2 CHD1 EIF3B ABCF1 CSNK1A1L TCERG1 DEK CBX5 LACTB CCDC40 | 1.54e-05 | 1450 | 40 | 12 | int:CIT |
| Interaction | TWIST1 interactions | 2.09e-05 | 170 | 40 | 5 | int:TWIST1 | |
| Interaction | IRF4 interactions | 2.40e-05 | 85 | 40 | 4 | int:IRF4 | |
| Interaction | BRD3 interactions | 4.71e-05 | 494 | 40 | 7 | int:BRD3 | |
| Interaction | H3C1 interactions | 5.36e-05 | 901 | 40 | 9 | int:H3C1 | |
| Interaction | H2BC21 interactions | 5.61e-05 | 696 | 40 | 8 | int:H2BC21 | |
| Interaction | PYHIN1 interactions | 6.95e-05 | 358 | 40 | 6 | int:PYHIN1 | |
| Interaction | CDK8 interactions | 7.45e-05 | 222 | 40 | 5 | int:CDK8 | |
| Interaction | HDAC4 interactions | 8.96e-05 | 744 | 40 | 8 | int:HDAC4 | |
| Interaction | CCDC181 interactions | 1.07e-04 | 8 | 40 | 2 | int:CCDC181 | |
| Interaction | PCNT interactions | 1.10e-04 | 241 | 40 | 5 | int:PCNT | |
| Interaction | RPL5 interactions | 1.69e-04 | 606 | 40 | 7 | int:RPL5 | |
| Interaction | CYTH1 interactions | 1.77e-04 | 55 | 40 | 3 | int:CYTH1 | |
| Interaction | PCM1 interactions | 1.99e-04 | 434 | 40 | 6 | int:PCM1 | |
| Interaction | LHX5 interactions | 2.09e-04 | 11 | 40 | 2 | int:LHX5 | |
| Interaction | ARHGAP42 interactions | 2.29e-04 | 60 | 40 | 3 | int:ARHGAP42 | |
| Interaction | H3C14 interactions | 2.54e-04 | 156 | 40 | 4 | int:H3C14 | |
| Interaction | SLC26A7 interactions | 2.95e-04 | 13 | 40 | 2 | int:SLC26A7 | |
| Interaction | ARHGAP24 interactions | 3.65e-04 | 486 | 40 | 6 | int:ARHGAP24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q13 | 2.35e-03 | 82 | 40 | 2 | chr13q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q23 | 5.78e-03 | 130 | 40 | 2 | chr14q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 6.40e-03 | 137 | 40 | 2 | chr1p22 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 3.20e-11 | 23 | 20 | 5 | 1288 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.19e-05 | 50 | 20 | 3 | 721 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.97e-04 | 19 | 20 | 2 | 832 | |
| GeneFamily | Phospholipases | 9.75e-04 | 42 | 20 | 2 | 467 | |
| GeneFamily | PHD finger proteins | 4.39e-03 | 90 | 20 | 2 | 88 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.68e-02 | 181 | 20 | 2 | 694 | |
| GeneFamily | RNA binding motif containing | 2.28e-02 | 213 | 20 | 2 | 725 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 2.87e-07 | 183 | 39 | 6 | M2993 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | HTATSF1 MCM7 SRGAP2C EIF3B SRGAP2B CCNB1IP1 UBN1 SGO1 MNAT1 CBX5 BRD7 | 3.14e-06 | 1363 | 39 | 11 | M45782 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | 9.12e-06 | 721 | 39 | 8 | M10237 | |
| Coexpression | MARTIN_VIRAL_GPCR_SIGNALING_DN | 6.40e-05 | 52 | 39 | 3 | M1330 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 1.34e-04 | 176 | 39 | 4 | M2981 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 1.47e-04 | 180 | 39 | 4 | M2961 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | 1.50e-04 | 550 | 39 | 6 | M16189 | |
| Coexpression | CHICAS_RB1_TARGETS_SENESCENT | 1.74e-04 | 565 | 39 | 6 | M2125 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 1.76e-04 | 73 | 39 | 3 | MM3841 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS | 1.77e-04 | 356 | 39 | 5 | M43609 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | 1.84e-04 | 571 | 39 | 6 | MM1100 | |
| Coexpression | GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION | 1.94e-04 | 14 | 39 | 2 | M14308 | |
| Coexpression | GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 2.07e-04 | 197 | 39 | 4 | M5342 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN | 2.11e-04 | 198 | 39 | 4 | M6089 | |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_DC_DN | 2.11e-04 | 198 | 39 | 4 | M5208 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP | 2.20e-04 | 200 | 39 | 4 | M8026 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_DN | 2.20e-04 | 200 | 39 | 4 | M7599 | |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN | 2.20e-04 | 200 | 39 | 4 | M4538 | |
| Coexpression | GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN | 2.20e-04 | 200 | 39 | 4 | M4885 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_DN | 2.20e-04 | 200 | 39 | 4 | M3875 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | 3.52e-04 | 644 | 39 | 6 | M10501 | |
| Coexpression | ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1 | 3.95e-04 | 96 | 39 | 3 | M39216 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 4.05e-04 | 426 | 39 | 5 | M9516 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 4.18e-04 | 429 | 39 | 5 | M29 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.36e-07 | 469 | 39 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 4.32e-05 | 1459 | 39 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.57e-05 | 532 | 39 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 6.68e-05 | 1257 | 39 | 10 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 6.92e-05 | 387 | 39 | 6 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 7.03e-05 | 778 | 39 | 8 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.50e-04 | 311 | 39 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 2.64e-04 | 68 | 39 | 3 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.13e-04 | 72 | 39 | 3 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k4_1000 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.10e-07 | 176 | 40 | 5 | b794275fdd757b8fa2108e3c867f23da2649146d | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 7.44e-07 | 190 | 40 | 5 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.44e-07 | 190 | 40 | 5 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 8.03e-07 | 193 | 40 | 5 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.24e-07 | 194 | 40 | 5 | 7c7091de47359760003e910cfbe63db5c99410d6 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 8.45e-07 | 195 | 40 | 5 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.40e-05 | 164 | 40 | 4 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.62e-05 | 170 | 40 | 4 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 172 | 40 | 4 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 177 | 40 | 4 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 178 | 40 | 4 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-05 | 179 | 40 | 4 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 181 | 40 | 4 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-05 | 181 | 40 | 4 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-05 | 182 | 40 | 4 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 2.16e-05 | 183 | 40 | 4 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 183 | 40 | 4 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 183 | 40 | 4 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 183 | 40 | 4 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 185 | 40 | 4 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 185 | 40 | 4 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.25e-05 | 185 | 40 | 4 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 185 | 40 | 4 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | CV-Severe-3|Severe / Virus stimulation, Condition and Cluster | 2.35e-05 | 187 | 40 | 4 | 68cb43a73945f5e252530da25613f6b3f484b4d5 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.35e-05 | 187 | 40 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 188 | 40 | 4 | 047c4e0b03fc8334e38c48977e41d26dbe229d47 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.50e-05 | 190 | 40 | 4 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | IPF-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 2.50e-05 | 190 | 40 | 4 | f9c2a13c7f6460e3b348581be855b7281c8f70b5 | |
| ToppCell | Control-Myeloid-cDC2|Control / Disease state, Lineage and Cell class | 2.50e-05 | 190 | 40 | 4 | 4e481e42353d47af7991744000403af2873f6a41 | |
| ToppCell | Control-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 2.55e-05 | 191 | 40 | 4 | 11dfd8f38beb294f42710cfbd355cb089e1023c0 | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 2.55e-05 | 191 | 40 | 4 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 191 | 40 | 4 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 2.55e-05 | 191 | 40 | 4 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | COPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 2.55e-05 | 191 | 40 | 4 | 4e4887175200a57e1b041f2f131e3df774df3509 | |
| ToppCell | COPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class | 2.55e-05 | 191 | 40 | 4 | 2af6e4a6bd1f2193ece2131c3b7d976dd23a6966 | |
| ToppCell | IPF-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 2.55e-05 | 191 | 40 | 4 | 9fda87fb6bc5b8b6c0214ec909ebbc9f3f65319b | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.60e-05 | 192 | 40 | 4 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | IPF-Myeloid-cDC2|IPF / Disease state, Lineage and Cell class | 2.60e-05 | 192 | 40 | 4 | fe1de692fec48cba4a9bbc6eaa257260e8b4e800 | |
| ToppCell | IPF-Myeloid-ncMonocyte|IPF / Disease state, Lineage and Cell class | 2.60e-05 | 192 | 40 | 4 | e9fb8c57d8094f70fb492909b2bec40aa5f2e5b8 | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 2.60e-05 | 192 | 40 | 4 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | Control-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.66e-05 | 193 | 40 | 4 | 4cb938c346cc32ec122d11e6b9f25db20e0f7ff6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 193 | 40 | 4 | 3eaa0461618582a1754400624350d269d24e750a | |
| ToppCell | COPD-Myeloid-ncMonocyte|COPD / Disease state, Lineage and Cell class | 2.66e-05 | 193 | 40 | 4 | 936ca95995599356b794fba32bfd82d8de339365 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.66e-05 | 193 | 40 | 4 | ecbe1bd16df547427da5e69a3017300e766c2899 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.71e-05 | 194 | 40 | 4 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | ILEUM-inflamed-(3)_moDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.71e-05 | 194 | 40 | 4 | c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43 | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.71e-05 | 194 | 40 | 4 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.71e-05 | 194 | 40 | 4 | bde6830a281f7cd7fd1733e40a41ddd2673ba88e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 194 | 40 | 4 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 2.71e-05 | 194 | 40 | 4 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.77e-05 | 195 | 40 | 4 | 3c5b7cce4a1c4b28fa3b657cce4148669a59e55e | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 195 | 40 | 4 | e9c7eb0b1a2d58f69b4e839665101948bd4527b8 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 195 | 40 | 4 | 7ae732f100e9a3c6062be5b877efa1ec9d5b3958 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 195 | 40 | 4 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-05 | 195 | 40 | 4 | f289a44010788853d7726d4b5aa75f3c62186c08 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 196 | 40 | 4 | 5ddd314d3def3776dc7da83778d41c6436ca51ac | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors|bone_marrow / Manually curated celltypes from each tissue | 2.82e-05 | 196 | 40 | 4 | 4143dab6dce3c88c9b002c64699ab453149990e7 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.88e-05 | 197 | 40 | 4 | e567886d69c6ea8dec87019c2ebc593793cb3107 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-05 | 197 | 40 | 4 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.88e-05 | 197 | 40 | 4 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 197 | 40 | 4 | 9b2c67de46bd59bf56c81a0d10b84cf4a041c120 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.88e-05 | 197 | 40 | 4 | a902aa05e5f711bcfdd9e19749ab636b597eb116 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 197 | 40 | 4 | f84f0ddf51208764ab56408d97035bbff562e59d | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 197 | 40 | 4 | a0d463825b62de49466f9fa563405dda4387cfff | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 198 | 40 | 4 | 8bd9be3f57e7a27935c63c913e486872d52600e7 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.94e-05 | 198 | 40 | 4 | 06888fe2d42ac66ac12157608becd42764e0d034 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.94e-05 | 198 | 40 | 4 | bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.00e-05 | 199 | 40 | 4 | 8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3 | |
| ToppCell | remission-T/NK_proliferative|World / disease stage, cell group and cell class | 3.00e-05 | 199 | 40 | 4 | f305f3a454b7d2170429bad087480ccccca19acd | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.00e-05 | 199 | 40 | 4 | 4394dcd1809f49e9bada8f5e115d5123356eae3e | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.00e-05 | 199 | 40 | 4 | 99778178e3ec121802db938db8c5475d19b43fec | |
| ToppCell | remission-T/NK_proliferative|remission / disease stage, cell group and cell class | 3.00e-05 | 199 | 40 | 4 | 303a5fc43a48b05b6f2060d99eef4adc36f8d4e3 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.00e-05 | 199 | 40 | 4 | 8daf945fc93169b0a4fa3ef9f4a87eedd52e314a | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease group, lineage and cell class | 3.00e-05 | 199 | 40 | 4 | 893b78c661c529db07a5fcc3124d9b3d0f270fa5 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.00e-05 | 199 | 40 | 4 | c0ea391bb347b99b94b5d7f02612ede938986745 | |
| ToppCell | COVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class | 3.00e-05 | 199 | 40 | 4 | c608d953b852b67a4e36bd63d45f0deec3eefbd9 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.00e-05 | 199 | 40 | 4 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.00e-05 | 199 | 40 | 4 | 5b18e18ddbf4bd53aa0d574d23092cb96da7f400 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.00e-05 | 199 | 40 | 4 | 6df65f4c2f9a125e0c7c4f597fefc05a97fc8831 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 199 | 40 | 4 | e3b69608c834bd8ce6bedde298a2763cc0d7d573 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.00e-05 | 199 | 40 | 4 | cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.00e-05 | 199 | 40 | 4 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.00e-05 | 199 | 40 | 4 | 53b3d35767889a152f1f38e8f6f0ba8f7a7690f2 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.00e-05 | 199 | 40 | 4 | 96af1f289552f38f2dfa181192eb3276f4c7d70b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-05 | 199 | 40 | 4 | 9940f347973bf976ee23fb4b1cf1f349d96c21df | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-05 | 200 | 40 | 4 | 5d11a2c0021805e78d97dc1638bf73ca1faede66 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-05 | 200 | 40 | 4 | 97e47eb69d1d4cab45256acca9589837eb7817e7 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.05e-05 | 200 | 40 | 4 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.05e-05 | 200 | 40 | 4 | cab374b7c56310329951c2ca44a7179ffa895b7d | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Slc17a7-Slc17a6.Calb1-Rorb-Il1rapl2_(Layer_5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.10e-05 | 80 | 40 | 3 | 402aba070f0728ebda9db7a8fa85441533755ff4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-04 | 141 | 40 | 3 | 31e0984f09983e83a814424f74c871c1c5a3a789 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-04 | 141 | 40 | 3 | d7d3c3932651d90fa4f3c4e3df16f4b677faaf9f | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-2|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.79e-04 | 142 | 40 | 3 | 959af19add016f21c814c28604d0177b88ebed12 | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 3.21e-04 | 149 | 40 | 3 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 3.68e-04 | 156 | 40 | 3 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| Disease | Neurodevelopmental Disorders | 2.18e-04 | 93 | 37 | 3 | C1535926 | |
| Disease | cholesteryl ester 22:6 measurement | 7.41e-04 | 32 | 37 | 2 | EFO_0010350 | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 7.41e-04 | 32 | 37 | 2 | EFO_0021870 | |
| Disease | Polynesian Bronchiectasis | 8.87e-04 | 35 | 37 | 2 | C4317124 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 8.87e-04 | 35 | 37 | 2 | C4551906 | |
| Disease | Kartagener Syndrome | 8.87e-04 | 35 | 37 | 2 | C0022521 | |
| Disease | skin microbiome measurement | 1.10e-03 | 39 | 37 | 2 | EFO_0801228 | |
| Disease | reading and spelling ability | 1.18e-03 | 166 | 37 | 3 | EFO_0005301 | |
| Disease | folic acid measurement | 1.53e-03 | 46 | 37 | 2 | EFO_0005111 | |
| Disease | Primary Ciliary Dyskinesia | 1.60e-03 | 47 | 37 | 2 | C4551720 | |
| Disease | acute myeloid leukemia (is_marker_for) | 1.73e-03 | 49 | 37 | 2 | DOID:9119 (is_marker_for) | |
| Disease | cognitive behavioural therapy | 2.42e-03 | 58 | 37 | 2 | EFO_0007820 | |
| Disease | blood lead measurement | 3.12e-03 | 66 | 37 | 2 | EFO_0007040 | |
| Disease | body fat percentage | 3.17e-03 | 488 | 37 | 4 | EFO_0007800 | |
| Disease | schizophrenia (implicated_via_orthology) | 3.31e-03 | 68 | 37 | 2 | DOID:5419 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | 3.95e-03 | 1228 | 37 | 6 | EFO_0004713 | |
| Disease | Autism Spectrum Disorders | 5.12e-03 | 85 | 37 | 2 | C1510586 | |
| Disease | lung adenocarcinoma (is_marker_for) | 5.12e-03 | 85 | 37 | 2 | DOID:3910 (is_marker_for) | |
| Disease | serum iron measurement | 5.23e-03 | 86 | 37 | 2 | EFO_0006332 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KEKKKLKKQMEYERQ | 256 | Q8NE71 | |
| KKDLKKYSKIFEQKD | 721 | P55884 | |
| FMKKYKKMKEGENNK | 66 | P45973 | |
| KKDKDMLEDKFKSNN | 296 | Q9NPI1 | |
| EKMLAKQKVSDMKYK | 406 | Q05D60 | |
| KKKVKTYQKSKEQMQ | 841 | Q8IWG1 | |
| MKKLDNYKKKDQETK | 346 | O14646 | |
| KKKMKNENADKLLKS | 551 | Q76M96 | |
| EIAKIKMEAKKKYEK | 226 | O75665 | |
| NMKISQKKLKKYEKE | 806 | Q9Y3P9 | |
| KKRKKDEEEKQAMYS | 3866 | Q8NEZ4 | |
| DNTKKKMEIYQKENK | 116 | P51948 | |
| GQKSKMKKMKEKYKD | 871 | O60524 | |
| KEEKAYKALKMMKEN | 231 | P83111 | |
| KKKKSKEKYIDQELN | 101 | Q58FG0 | |
| VKYNSKKMKKLEKEY | 401 | O60447 | |
| AMTKKQKYEKISEKK | 226 | Q8N752 | |
| MALKDYALEKEKVKK | 1 | P33993 | |
| KADKNKDNKMSFKEL | 151 | P51178 | |
| TKMDLEKYKVQKDLK | 426 | Q96LP2 | |
| KKCKDYKKKLSMQQK | 231 | O43719 | |
| KKKRKQDYTDAMKKL | 531 | Q9Y2L6 | |
| YQKKKELDKLQTKMS | 256 | P0C221 | |
| EKGSVQYKKKEEMLK | 136 | P35659 | |
| AYKKSIMKEEEKNEK | 536 | Q4G0X9 | |
| KKIEKMKEKRQAKYS | 216 | Q7Z6B7 | |
| KQKDCKMKLKEFVDY | 166 | O75151 | |
| MSKYKENKSENKKTV | 306 | Q5FBB7 | |
| KKIEKMKEKHQAKYT | 226 | P0DJJ0 | |
| KKIEKMKEKRQAKYT | 226 | P0DMP2 | |
| RNKMYKDKYKKKKSD | 166 | O00287 | |
| IKFEAKEAKNKKMKA | 2066 | Q8NFU7 | |
| KEAKNKKMKASEQKD | 2071 | Q8NFU7 | |
| MKKVLEEYKKKFSDI | 146 | Q9NPC3 | |
| KKIEKMKEKRQAKYS | 216 | O43295 | |
| KKNKIMQAKEDFKKM | 721 | O14776 | |
| KKIEKMKEKRQAKYT | 226 | O75044 | |
| KLQKKHYKEMKDLVK | 921 | Q9NQ66 | |
| NKEMLKYKKEKQQEE | 391 | Q9H6S0 | |
| KEMLKKFQKEKEAQK | 246 | Q9NPG3 | |
| EKNKKAMEIISEKKY | 1946 | P20929 | |
| VSEKKYKIQYEKMKD | 5226 | P20929 |